The importance of drug combinations for effective control of hypertension

Clinical and Experimental Hypertension

Volumn 21, Issue 5-6, 1999, Pages 875-884

  Chalmers, John ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Achieved blood pressure; Additive hypotensive effect; Fixed low dose combinations; Goals of therapy; Hypertension control in populations; Low dose combinations; Quality of life

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BISOPROLOL FUMARATE PLUS HYDROCHLOROTHIAZIDE; CALCIUM ANTAGONIST; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; INDAPAMIDE; PERINDOPRIL; VERAPAMIL;

AGING; ANGINA PECTORIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DOSE RESPONSE; DRUG MECHANISM; DRUG MIXTURE; DRUG POTENTIATION; ESSENTIAL HYPERTENSION; HUMAN; SYSTOLIC HYPERTENSION;

EID: 0032791703     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969909061016     Document Type: Conference Paper

References (19)

1. WHO-ISH Guidelines sub-Committee. 1993 Guidelines for the management of mild hypertension: Memorandum from a World Health Organisation/International Society of Hypertension Meeting. J Hypertens 1993, 11:905-918.
2. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint national Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC-VI). Arch Intern Med 1998, 157:2413-2446.
3. Chalmers, JP. The place of combination therapy in the treatment of hypertension in 993. Clin Exp Hypertens 1993, 15(6): 1299-1313.
4. Lindholm L, Ejlertsson G, Schersten B. High risk of cerebrocardiovascular morbidity in well treated male hypertensives: a retrospective study of 40-59 year old hypertensives in a Swedish primary care district. Acta Med Scand 1984, 216:251-259.
5. Isles CG, Walker LM, Beevers GD, et al. Mortality in patients of the Glasgow Blood Pressure Clinic. J Hypertens 1986, 4:141-156.
6. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease - part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990, 335:827-838.
7. Collins R, MacMahon S. Blood Pressure, antihypertensive drug treatment and the risks of stroke and coronary heart disease. Br Med Bull 1994, 50:272-298.
8. Burt VL, Cutler JA, Higgins M, et al. Trends in the prevalence, awareness, treatment and control of hypertension in the US adult population: data from the health examination surveys 1960 to 1991. Hypertension 1995, 26:60-69.
9. Burt VL, Whelton P, Rocella EJ, et al. Prevalence of hypertension in the US adult population. Results from the third national health and nutrition examination survey 1988-1991. Hypertension 1995, 25:305-313.
10. Mancia G, Sega R, Milesi C, Sesana C, Zanchetti A. Blood pressure control in the hypertensive population. Lancet 1997, 349:454-457.
11. Colhoun HM, Dong W and Poulter NR. blood pressure screening, management and control in England: results from the Health Survey for England 1994. J Hypertens 1998, 16:747-752.
12. De Henauw S, De Bacquer D, Fonteyne W, et al. Trends in the prevalence, selection, treatment and control of arterial hypertension in the Belgian adult population. J Hypertens 1998, 16:277-284.
13. National Heart Foundation of Australia. Heart and Stroke Facts: a report by the National Heart Foundation of Australia, Canberra, 1995.
14. Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood pressure lowering and low dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998, 351:1755-1762.
15. Wiklund I, Hailing K, Ryden-Bergsten T, Fletcher A on behalf of the HOT Study Group. Does lowering the blood pressure improve the mood? Quality of life results from the Hypertension Optimal Treatment (HOT) Study. Blood Pressure 1997, 6:357-364.
16. SHEP Co-operative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991, 265:3255-3264.
17. Staesen JA, Fagard R, Thijs L, et al for the Systolic Hypertension-Europe (Syst-Eur) Trial Investigators. Morbidity and mortality in the placebo-controlled European Trial on Isolated systolic Hypertension in the elderly. Lancet 1997, 350:757-764.
18. Wing LM, Arnolda LF, Harvey PJ, et al. Lacidipine, hypdrochlorothiazide and their combination in systolic hypertension in the elderly. J Hypertens 1988, 15:1503-1510.
19. Chalmers JP, Castaigne A, Mallion JM, Morgan T, Chastang C, Feldmann L, Guez D. Efficacy and acceptability of a new fixed low dose combination for initial therapy in hypertension. J Hypertens (in press).